SCHEMBL22257900

SCHEMBL22257900

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)sc3cc(-c5ccccc5-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)ccc34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.41
ATM Q13315 2/20 0.41
KDM4E B2RXH2 1/20 0.41
PTGER4 P35408 2/20 0.37
NPY5R Q15761 1/20 0.32
KMT2A Q03164 4/20 0.32
IL1R1 P14778 1/20 0.32
MEN1 O00255 3/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
HTT P42858 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
HPGD P15428 1/20 0.31
RAC2 P15153 1/20 0.31
RAC3 P60763 1/20 0.31
CDC42 P60953 1/20 0.31
RAC1 P63000 1/20 0.31
HSD17B10 Q99714 1/20 0.30
LIMK1 P53667 1/20 0.30
PDE1B Q01064 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26193539 0.99 L3MBTL1 (0.40) L3MBTL1ATMKDM4EPTGER4NPY5R
SCHEMBL22257992 0.97 KDM4E (0.38) L3MBTL1ATMKDM4EPTGER4NPY5R
SCHEMBL22257601 0.97 KDM4E (0.38) L3MBTL1ATMKDM4EPTGER4NPY5R
SCHEMBL12093251 0.94 L3MBTL1 (0.44) L3MBTL1ATMKDM4EPTGER4NPY5R
SCHEMBL21622664 0.94 L3MBTL1 (0.44) L3MBTL1ATMKDM4EPTGER4NPY5R
SCHEMBL22058035 0.94 KDM4E (0.38) L3MBTL1ATMKDM4EPTGER4NPY5R
SCHEMBL26193540 0.93 L3MBTL1 (0.41) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL24701820 0.93 ATM (0.43) L3MBTL1ATMKDM4EPTGER4NPY5R
SCHEMBL22240874 0.93 L3MBTL1 (0.43) L3MBTL1ATMKDM4EPTGER4NPY5R
SCHEMBL26193847 0.93 KDM4E (0.35) L3MBTL1ATMKDM4EPTGER4LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023163381-A1 HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC MATERIAL LAYER FORMATION COMPOSITION WHICH COMPRISE SAME 엘티소재주식회사 2023-08-31 WO disclosed
EP-4186898-A1 COMPOSITION FOR ORGANIC ELECTRONIC COMPOUNDS Merck Patent GmbH (DE) 2023-05-31 EP disclosed
US-20230150987-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
US-20230150987-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
US-20200231578-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150987-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO2A1, SLCO1B3 L3MBTL1 3258/4885ATM 4632/4885KDM4E 3745/4885
US-20200231578-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO2A1, SLCO1B3 L3MBTL1 3258/4885ATM 4632/4885KDM4E 3745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.